Cancer ABCs
A Mobile App To Track the Coronavirus and its ...

Stand Up To Cancer announced an initiative that will both help scientists understand the emerging coronavirus pandemic and ensure the needs of cancer patients and survivors are being included as the research goes forward.

A Mobile App To Track the Coronavirus and its Effects on People with Cancer
Medical Insurance, Medical Benefit Plans, Medicaid Expansion
Cancer ABCs
Cancer Insurance & Family Leave News

There are a number of items of news about state expansion of Medicaid, Family Leave and some attempts by certain states to screw their citizens who have cancer or chronic illnesses go around the federal medical insurance laws by

ADT

,

A New Standard of Care After Prostate Surgery

,
A New Standard of Care After Prostate Surgery

The standard of care has been to treat only the prostate surgery bed. The SPPORT study (RTOG/NRG Oncology 0534) was designed to see if adding short-term hormone therapy or short-term hormone therapy plus pelvic lymph node radiation significantly lowers recurrence and the risk of cancer spreading.

, ,

Hormone Therapy Plus Radiotherapy Improves Survival in Men with Localized Prostate Cancer

, ,
Hormone Therapy Plus Radiotherapy Improves Survival in Men with Localized Prostate Cancer

findings provide the strongest evidence so far to the magnitude of thesurvival benefit of ADT treatment intensification with radiotherapy for men with localized prostate cancer

Caution - Testosterone Flare During Transition from Degarelix to Leuprolide

Transitioning from Degarelix to Lupron can cause a dangerous PSA flare that needs to be avoided by adding an anti-androgen drug like Casodex prior to making the transition; not unlike when Lupron is started as an initial treatment.

,

Zytiga And Prednisone Provide Significant Benefits Beyond Survival With Newly Diagnosed Metastatic Hormone-Sensitive and Castration-Resistant Prostate Cancer

,

Zytiga And Prednisone Provide Significant Benefits Beyond Survival With Newly Diagnosed Metastatic Hormone-Sensitive and Castration-Resistant Prostate Cancer

,

Bisphosphonate Treatment for Men with Non-Metastatic Prostate Cancer Treated With ADT

,

The current standard of care for men with non-metastatic prostate cancer who are on hormone therapy (ADT) does not include the use of any of the bisphosphonate drugs.  Some men might benefit by using them at this stage.

Gold Guidestar Seal
Gold Transparency 2022